Terms ending in 2034
Every in-force patent on Purdue Pharma L.P.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,955,869 | System and Method for Supporting Health Management Services In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,714,252 | Cyclic Sulfonamides as Sodium Channel Blockers In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,056,836 | Benzomorphan Analogs and the Use Thereof In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,149,533 | Tamper Resistant Pharmaceutical Formulations In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,545,448 | Tamper Resistant Pharmaceutical Formulations In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,579,389 | Methods of Preparing Tamper Resistant Pharmaceutical Formulations In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,655,971 | Tamper Resistant Pharmaceutical Formulations In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,662,399 | Tamper Resistant Pharmaceutical Formulations In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 10,478,504 | Tamper Resistant Pharmaceutical Formulations In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 10,792,364 | Tamper Resistant Pharmaceutical Formulations In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| 36 more term ends in 2034 · Pro | |||||
10 of 46 patents shown. Soonest term end first, then patent number.
Pro members see all 46.
45 of these are in force and held by Purdue Pharma L.P..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.